Tag | Content |
---|
EnhancerAtlas ID | HS116-17138 |
Organism | Homo sapiens |
Tissue/cell | Left_ventricle |
Coordinate | chr19:30161730-30164730 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
MEF2A | MA0052.3 | chr19:30162545-30162557 | GCTAAAAATAGC | + | 6.44 | MEF2B | MA0660.1 | chr19:30162545-30162557 | GCTAAAAATAGC | + | 6.92 | MEF2C | MA0497.1 | chr19:30162543-30162558 | AAGCTAAAAATAGCA | + | 8.03 | NFE2L1 | MA0089.2 | chr19:30162847-30162862 | AGAGCTGAGTCATGC | - | 6.23 | REL | MA0101.1 | chr19:30164516-30164526 | GGAAATCCCC | - | 6.02 |
|
| Number of super-enhancer constituents: 23 | ID | Coordinate | Tissue/cell |
SE_01995 | chr19:30162190-30164011 | Aorta | SE_03500 | chr19:30162856-30163592 | Brain_Angular_Gyrus | SE_04418 | chr19:30161971-30164004 | Brain_Anterior_Caudate | SE_05104 | chr19:30161943-30175216 | Brain_Cingulate_Gyrus | SE_05992 | chr19:30161895-30175512 | Brain_Hippocampus_Middle | SE_07189 | chr19:30161916-30170161 | Brain_Hippocampus_Middle_150 | SE_08055 | chr19:30161921-30164788 | Brain_Inferior_Temporal_Lobe | SE_12389 | chr19:30161691-30165248 | CD3 | SE_15294 | chr19:30161517-30168364 | CD4_Memory_Primary_7pool | SE_16572 | chr19:30161499-30165474 | CD4_Naive_Primary_8pool | SE_18169 | chr19:30155285-30168956 | CD4p_CD25-_CD45ROp_Memory | SE_19560 | chr19:30161728-30168512 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_20556 | chr19:30155335-30172521 | CD56 | SE_21321 | chr19:30161657-30165390 | CD8_Memory_7pool | SE_40973 | chr19:30161560-30165126 | Left_Ventricle | SE_41671 | chr19:30162218-30163132 | LNCaP | SE_41671 | chr19:30163219-30167352 | LNCaP | SE_42924 | chr19:30161733-30165058 | Lung | SE_48180 | chr19:30153054-30174554 | Psoas_Muscle | SE_48808 | chr19:30161040-30164995 | Right_Atrium | SE_49565 | chr19:30162474-30163503 | Right_Ventricle | SE_51595 | chr19:30160892-30165284 | Skeletal_Muscle | SE_55264 | chr19:30162098-30165400 | Thymus |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | CTCGCCACCA CACCAGGCTA ATTTTTTGTA TTTTAAGAGA CAGAGTTTCA CCGTGTTGGC 60 CAGGATGGTC TAGATCTCCT GACCTCATGA TCCCCCCTCC TCGGCCTCCC AAAGTGCTGG 120 GATTACAGGC GTGAGTATTT TTAACTTTTT AAGGAACTTC CATGCTGTTT TCCTTAGGGG 180 CTGCACCAGT TCCTATTCTC ATCAGCAGTG CACAGTTTCC AGTTTCTCCA CACCCTCACC 240 AACACTTGTT ATTTATTTTT TGTTTTGTTT TTTTCCCCTC CTTTTTTTTT TTTTGAGATG 300 GAATCTCACT CTGTCACACA GGCTGGAGTG CAATGGCGCC ATCTTGGCTC ACTGCAACCT 360 CTGCTTCCTG GGTTCAAGCG ATTCTCCTGC CTCCGCCTCC CGAGTAGCTG GAATTACAGG 420 TGTGAGGCAC TGTGTCCGGC CTTCCTCCTA CCTATTTTTA TTCATAGATA TAGTTCTTGA 480 ACACTTTCAG AATGTTATGT AATTCCTGCA TAAGTGGTGT CACTTTACAT ACAACATTCT 540 ACAGGCTGTG TTTTTCCACT CCACGTTTGT TGTTTGCCGT CAGACCACAT TGATCTGTAT 600 CTCTCATTGC GTGAGTAGCC CCGGGTTTTT ATCCTTTTCC CTGCTGGTAG GCATTTTGGT 660 TGTCTCTGCT GGGCAGTCAT TGCTCTTTGT GGAATGCAGT TCTGGTTTTG TCAGATTGTC 720 CCTCAGCCAG GTACTCGGTG ATCAGTCATG GTGGGACAGG TCAGTTCTGT CACTGGTAAT 780 CCCCTAGGTT TGCAGTATAC AGCCAAGATC AGCAAGCTAA AAATAGCAGT TCTTACGTAA 840 GGTAGTGTGG GCAGCCCTTC TCAGGACACT TGTGATCTGC AGGGGCAAGT GGAACGGGAC 900 TCGAGGGCCC AGCATCTTCT GTTCTGCAAT GCATCCACCC TCACACTGGG GCCCCACTCT 960 GGCTTTCTAC TGGTGGCCAG GCTCAGAACT GCAGCTCAGT GACCCAGAAA CACTATGGGT 1020 GTGATCAGCT CAGCCCCAGG CGTGCCGTGT GTACCGGAAT GCATGTGTGC ACGTGGTGGT 1080 GGTGGGGCCA GCTCTCACCT CTTCCTCTGT AGAGGTAAGA GCTGAGTCAT GCATGGTGGG 1140 CCTTGGGACC TGCTTGGAAC CGTGCCAAGC TACTTATGAA GCATCTAGTA TGTGCTTGGC 1200 ATGGCTCCAA GAATTGTGGA CACAATGAAC AAGAAGAAGC TCCTGTTCTC ATGGAGCTAA 1260 GAACTGAGCA GGGAAGCAGA AAACACACAA GCAATGAATA GACAAGCAAA CAGCAGGTCC 1320 TGTTAAATCC CACAAAGAAA AACGATTGAA TCCCAGAGAA GTGGCCAGCA GACCTTTTCT 1380 ACAAAGGGCC AGGTGGTGAA TATTTTAGGC TTTGTCACCA TGTAGTCCCT GTCACCAACA 1440 CTCAACTCTC CCATTGCAGT GTGGAAGCCA CCAGAGACAA TAATAAATGA ACGAATGTGG 1500 CTGTGTCCCA ATAAATCTTT AACAAAAGCA GGCTGAGGGC CGGATTTGAC TCTCAGACCT 1560 TGGATTACCA ATGCTTGTCC TGGGTGTGGG AAGAGGCTGC CTGAGCTGGG GTTGTCAGGG 1620 AGAACCCTTT CAAAAAGGAA CTGAGAACCC GTTGCAGGAA GGAGCTGACC CTGGGACAGC 1680 CTGTCTCAGG TAGGACACAA TGGCACCTTG CCACCGATAT GGTGGCGGAG TTATGTGCTG 1740 AGAAATGGGC AGGCTAGATT TGAGAGGTAA AGATGATGAG ATTTACTCAT GGCTTGAATA 1800 TTGGAGGTAC AGGAAGGGGG AGATTCAAGG ATGTGTCCTA GGTCTGGGGT TTGAACTCCT 1860 GGATGAATGG TGGTGTCACT GAAGGAGAGG AAGAGGTGCA GGTCTGCGGA GGTTTGTTGT 1920 TGGATGTGTT GAGTTTGAGG AGCTTATTAG ACAAGCAGGT GAACATCTAT GCTGACAGCC 1980 CTCCTAGAGC TTGGAGAGGC CAAGACTGGA GGCTTGGAAT GGGGAATCTA TGGCATTTAT 2040 GGGGTCTTCA AGGTCGTGAG TCTGGTGGGC TGGTGTGTGT GTGGACCAAG CAGGGGGCGC 2100 CCGGCATGAG CTCTGAGTTA GTGCTTAGTG CTTAGGGCAC CAACAGAGGG GCCTGTGTGG 2160 CCTCACACTC CACTCGGGAC GGCAGCATAG TGCGAGCTCC AGGGCCCCTG CCTCCTAGCA 2220 TCGCCTCAGT TCCCCTCCTG TAAAGTGGGG ATTCTGCCTT CTGGGGTTGG GTGGGAACTA 2280 AATGAGATAG TCACGCTTGG CTGACAGGAA GCACTCGGCG CCTGTGCTTG TGATGGTGGT 2340 GGTGACTGCT GCACTTCCTG GGTGGTTGCG TGGGTTGCAG GGCCTGTGAC AGCTTGGTTT 2400 GGTGGATGGC AGAGTCAGGG TTGGGTTGGG GGTAGAGACA CCCAGGTCTC CTGGCACAGA 2460 CCGTTCTGAT GTCCCGTTGA GGCCTGTTCC GCCCTGTTTT TCAAGGCTCC CCAGCGGGGC 2520 TGAACCTCTG CCCTCTGCTG CCCACAGTAG TAGCCGGCTC AGTAGCACTT TTTTTTTTTA 2580 AGAGATAGAA TCCACTCAGT CACCTAGCTA GAGTGTAGTG GCATGATCAT AGCTCACTGT 2640 AGCCTCAAAC TCCTGGGCTC GAGCCTCCTC TTGCCTCAGC CTTCCAAAAC GCTGGAACCA 2700 CAGGCATGAA CCGCTGCACC TGGCCTAAGT AGCACACTTT ATCACTGCCT TCCCATCCCT 2760 GTCTGGCCTC CACATCCCCT TTACTGGGAA ATCCCCCTTC CCTCCCCGTA GTTCCCTGTA 2820 CTCCCGTCTA AGGGTCAGCT TCCGAGGTGA TGCTTCTCAG TGCTGGGCAG GCCTGCGGGT 2880 TACTGTGCGT AGTCAGTGGG CTGCCTGGCA TGGTGGGTTA GTCAGTTGGG GGTGGGCAGC 2940 GTGGTTCTGA CACCCCCATG CCTGAGCCTG GACATACTCC TTGTCTGTCT CCTCCTGCAG 3000
|